Clonal evolution and mechanisms of acquired resistance to CDK4/6 inhibitors in ER-wild type and ER-mutant breast cancer

被引：4
|
作者：
Guarducci, Cristina
Cristea, Simona
Feit, Avery
Naumenko, Sergey
Nardone, Agostina
Ma, Wen
Russo, Douglas
Feit, Gabriella Cohen
Feiglin, Ariel
Hermida-Prado, Francisco
Sherman, Shira
Brown, Myles
Michor, Franziska
Jeselsohn, Rinath
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-GS3-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GS3-07
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Unveiling mechanisms of CDK4/6 inhibitor resistance in ER plus breast cancer models with acquired resistance
    Li, Bin
    Liu, Gaoxiang
    Ni, Ting
    Shi, Wenting
    Gu, Qingyang
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Mechanisms of resistance to CDK4/6 inhibition in ER plus breast cancer
    Lee, N. V.
    Eisele, K. J.
    Chionis, J.
    Yuan, J.
    Zhu, Z.
    Liu, C.
    Li, D.
    Olson, P. A.
    Fantin, V.
    Arndt, K. T.
    Shields, D. J.
    VanArsdale, T. L.
    CANCER RESEARCH, 2016, 76
  • [3] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    CANCER GENE THERAPY, 2022, 29 (06) : 859 - 869
  • [4] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Olesya A. Kharenko
    Reena G. Patel
    Cyrus Calosing
    Edward H. van der Horst
    Cancer Gene Therapy, 2022, 29 : 859 - 869
  • [5] Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
    Masafumi Iida
    Daichi Toyosawa
    Misato Nakamura
    Kouki Tsuboi
    Emi Tokuda
    Toshifumi Niwa
    Takanori Ishida
    Shin-ichi Hayashi
    Breast Cancer, 2020, 27 : 963 - 972
  • [6] Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
    Iida, Masafumi
    Toyosawa, Daichi
    Nakamura, Misato
    Tsuboi, Kouki
    Tokuda, Emi
    Niwa, Toshifumi
    Ishida, Takanori
    Hayashi, Shin-ichi
    BREAST CANCER, 2020, 27 (05) : 963 - 972
  • [7] Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
    C Yang
    Z Li
    T Bhatt
    M Dickler
    D Giri
    M Scaltriti
    J Baselga
    N Rosen
    S Chandarlapaty
    Oncogene, 2017, 36 : 2255 - 2264
  • [8] Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
    Yang, C.
    Li, Z.
    Bhatt, T.
    Dickler, M.
    Giri, D.
    Scaltriti, M.
    Baselga, J.
    Rosen, N.
    Chandarlapaty, S.
    ONCOGENE, 2017, 36 (16) : 2255 - 2264
  • [9] Acquired sensitivity strategies in ER plus breast cancer progressing on CDK4/6 and mTOR inhibitors
    Farmaki, Eleni
    Emond, Rena
    Cosgrove, Patrick
    Bild, Andrea
    CANCER RESEARCH, 2022, 82 (04)
  • [10] EGFR signaling contributes to acquired resistance to CDK4/6 inhibitors in ER plus breast cancer cells in vitro and in vivo
    Lypova, Nadiia
    Lanceta, Lilibeth
    Daugherty, Susan
    Chesney, Jason
    Imbert-Fernandez, Yoannis
    CANCER RESEARCH, 2023, 83 (05)
12345